CMF-01217 | IRAK3 | down-regulates | SMAD3 | activates | R-2549 | 15 | 2 | Drugs (3) |
CMF-02248 | GPR65 | up-regulates | SMAD3 | activates | R-2543 | 15 | 2 | Drugs (7) |
CMF-02249 | GPR65 | up-regulates | SMAD3 | activates | R-2538 | 15 | 2 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-02714 | ABCA5 | up-regulates | SMAD3 | activates | R-2538 | 15 | 2 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-03852 | DSP | up-regulates | SMAD3 | activates | R-2550 | 15 | 4 | Drugs (1) |
CMF-05094 | SPEG | down-regulates | SMAD3 | activates | R-2543 | 15 | 3 | Drugs (7) |
CMF-05095 | SPEG | down-regulates | SMAD3 | activates | R-2549 | 15 | 3 | Drugs (3) |
CMF-05096 | SPEG | down-regulates | SMAD3 | activates | R-2541 | 15 | 3 | Drugs (3) |
CMF-15409 | DSE | up-regulates | SMAD3 | activates | R-2550 | 15 | 3 | Drugs (1) |
CMF-17471 | OR5L2 | up-regulates | SMAD3 | activates | R-2543 | 15 | 3 | Drugs (7) |
CMF-17619 | ODZ1 | down-regulates | SMAD3 | activates | R-2538 | 15 | 3 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-18975 | CLEC14A | up-regulates | SMAD3 | activates | R-2539 | 15 | 3 | Drugs (10) |
CMF-18976 | CLEC14A | up-regulates | SMAD3 | activates | R-2549 | 15 | 3 | Drugs (3) |
CMF-18977 | CLEC14A | up-regulates | SMAD3 | activates | R-2541 | 15 | 3 | Drugs (3) |
CMF-19422 | NF1 | up-regulates | SMAD3 | activates | R-2543 | 15 | 7 | Drugs (7) |
CMF-19423 | NF1 | up-regulates | SMAD3 | activates | R-2546 | 15 | 7 | Drugs (1) |
CMF-19425 | NF1 | up-regulates | SMAD3 | activates | R-2539 | 15 | 7 | Drugs (10) |
CMF-19426 | NF1 | up-regulates | SMAD3 | activates | R-2549 | 15 | 7 | Drugs (3) |
CMF-19427 | NF1 | up-regulates | SMAD3 | activates | R-2541 | 15 | 7 | Drugs (3) |
CMF-19428 | NF1 | up-regulates | SMAD3 | activates | R-2538 | 15 | 7 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-21260 | EGR1 | up-regulates | SMAD3 | activates | R-2543 | 15 | 3 | Drugs (7) |
CMF-21262 | EGR1 | up-regulates | SMAD3 | activates | R-2538 | 15 | 3 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-24502 | SEMA3C | down-regulates | SMAD3 | activates | R-2543 | 15 | 6 | Drugs (7) |
CMF-24503 | SEMA3C | down-regulates | SMAD3 | activates | R-2546 | 15 | 6 | Drugs (1) |
CMF-24505 | SEMA3C | down-regulates | SMAD3 | activates | R-2550 | 15 | 6 | Drugs (1) |
CMF-24506 | SEMA3C | down-regulates | SMAD3 | activates | R-2549 | 15 | 6 | Drugs (3) |
CMF-24507 | SEMA3C | down-regulates | SMAD3 | activates | R-2538 | 15 | 6 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-24892 | ELMO1 | down-regulates | SMAD3 | activates | R-2549 | 15 | 1 | Drugs (3) |
CMF-25213 | KIF13A | down-regulates | SMAD3 | activates | R-2549 | 15 | 1 | Drugs (3) |
CMF-25220 | CPNE7 | up-regulates | SMAD3 | activates | R-2538 | 15 | 1 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-25442 | PCDHGB3 | up-regulates | SMAD3 | activates | R-2549 | 15 | 4 | Drugs (3) |
CMF-25444 | PCDHGB3 | up-regulates | SMAD3 | activates | R-2538 | 15 | 4 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |
CMF-27746 | C21orf29 | down-regulates | SMAD3 | activates | R-2549 | 15 | 1 | Drugs (3) |
CMF-27790 | CSMD3 | down-regulates | SMAD3 | activates | R-2543 | 15 | 3 | Drugs (7) |
CMF-27791 | CSMD3 | down-regulates | SMAD3 | activates | R-2550 | 15 | 3 | Drugs (1) |
CMF-29069 | DNAH3 | up-regulates | SMAD3 | activates | R-2538 | 15 | 1 | Drugs (44) Regulator Drugs (0)Regulon Drugs (44)POZIOTINIB, MM-111, TRASTUZUMAB DERUXTECAN, VARLITINIB, CUDC-101, LAPATINIB DITOSYLATE, TUCATINIB, HEMAY-022, MP-412, TRASTUZUMAB EMTANSINE, ZENOCUTUZUMAB, CANERTINIB DIHYDROCHLORIDE, NERATINIB MALEATE, MUBRITINIB, LAPATINIB, SAPITINIB, NERATINIB, BMS-690514, AC-480, DACOMITINIB, KBP5209, TARLOXOTINIB, VANDETANIB, ALLITINIB, ERTUMAXOMAB, TRASTUZUMAB DUOCARMAZINE, MARGETUXIMAB, TRASTUZUMAB, T-DM1, CANERTINIB, BDTX189, JNJ-26483327, TESEVATINIB, JI-101, AFATINIB DIMALEATE, CP-724714, AFATINIB, TG100-801, AEE-788, PYROTINIB, TAK-285, PERTUZUMAB, GSK-690693, GANCOTAMAB |